Sort
21,281 grants matching “influenza”
The N-Glycosylation Pathway And Signaling By Free Mannose-6-Phosphate
$413,400Mark Andrew Lehrman · Ut Southwestern Medical Center · R01 · FY2017 · GM
The N-Glycosylation Pathway And Signaling By Free Mannose-6-Phosphate
$413,400Mark Andrew Lehrman · Ut Southwestern Medical Center · R01 · FY2016 · GM
The N-Glycosylation Pathway And Signaling By Free Mannose-6-Phosphate
$413,400Mark Andrew Lehrman · Ut Southwestern Medical Center · R01 · FY2014 · GM
The N-Glycosylation Pathway And Signaling By Free Mannose-6-Phosphate
$413,400Mark Andrew Lehrman · Ut Southwestern Medical Center · R01 · FY2015 · GM
Systems Immunology
$413,384John S Tsang · University Of Maryland Baltimore · U19 · FY2022 · AI
Identification of rare variants that disrupt signaling pathways and networks inv
$413,348Steven M Wolinsky · Icahn School Of Medicine At Mount Sinai · U19 · FY2017 · AI
IRF4 and immunity to influenza infection
$413,342Jie Sun · Indiana University Indianapolis · R01 · FY2015 · AI
Chimeric enzyme for nucleic acid autohydrolysis
$413,338James Williams · Nature Technology Corporation · R44 · FY2007 · GM
Molecular Mechanisms of Rhabdovirus Entry
$413,330Sean P. J. Whelan · Harvard Medical School · R01 · FY2014 · AI
Translational Control in Influenza Virus Infected Cells
$413,329Michael G Katze · University Of Washington · R01 · FY2009 · AI
Evaluation of the immune responses to influenza virus vaccines and efficacy of immunotherapeutics in the ferret model
$413,325Adolfo Garcia-Sastre · Icahn School Of Medicine At Mount Sinai · P01 · FY2018 · AI
Influenza vaccines inducing broadly cross protective immunity
$413,221Sang-Moo Kang · Georgia State University · R01 · FY2015 · AI
Influenza vaccines inducing broadly cross protective immunity
$413,221Sang-Moo Kang · Georgia State University · R01 · FY2012 · AI
Influenza vaccines inducing broadly cross protective immunity
$413,221Sang-Moo Kang · Georgia State University · R01 · FY2014 · AI
Role of pathogenic Parkinsonian mutations in the seeding and propagation of alpha-synuclein in the CNS
$413,108Richard J Smeyne · Thomas Jefferson University · R01 · FY2022 · NS
Role of pathogenic Parkinsonian mutations in the seeding and propagation of alpha-synuclein in the CNS
$413,108Richard J Smeyne · Thomas Jefferson University · R01 · FY2020 · NS
Role of pathogenic Parkinsonian mutations in the seeding and propagation of alpha-synuclein in the CNS
$413,108Richard J Smeyne · Thomas Jefferson University · R01 · FY2021 · NS
Role of pathogenic Parkinsonian mutations in the seeding and propagation of alpha-synuclein in the CNS
$413,108Richard J Smeyne · Thomas Jefferson University · R01 · FY2023 · NS
High-throughput screening for novel adjuvant discovery for vaccines against influenza virus
$413,000Nikolai Petrovsky · Vaxine Pty Ltd · N01 · FY2019 · AI
System Immunogenetics of SARS-CoV Infection
$412,965Ralph S Baric · Univ Of North Carolina Chapel Hill · U19 · FY2015 · AI
System Immunogenetics of Influenza-Induced Innate and Adaptive Immunity in the L
$412,964Mark T Heise · Univ Of North Carolina Chapel Hill · U19 · FY2015 · AI
Oncolytic Virus Therapeutic Responses Occur from Changes in the Glioblastoma Immune Microenvironment
$412,964E. Antonio Chiocca · Brigham And Women'S Hospital · R01 · FY2025 · NS
Peripheral CD8+ T Cell Tolerance
$412,940Scripps Research Institute · R01 · FY2005 · DK
Peripheral CD8+ T Cell Tolerance
$412,940Scripps Research Institute · R01 · FY2004 · DK
STRENGTHENING THAILAND'S INFLUENZA SURVEILLANCE NETWORK TO SUPPORT INFLUENZA CONT
$412,939Pathom Sawanpanyalert · National Institute Of Health · U51 · FY2012 · IP